| Assay Method Information | |
| | Neprilysin Inhibition Assay |
| Description: | NEP inhibitors, such as thiorphan, candoxatril, and candoxatrilat, have been studied as potential therapeutics. Compounds that inhibit both NEP and angiotensin-I converting enzyme (ACE) are also known, and include omapatrilat, gempatrilat, and sampatrilat. Referred to as vasopeptidase inhibitors, this latter class of compounds is described in Robl et al. (1999) Exp. Opin. Ther. Patents 9(12): 1665-1677. |
| Affinity data for this assay | |
|---|---|
| If you find an error in this entry please send us an E-mail | |